Abstract
The Human Genome Project has heralded a whole new era in our understanding of the molecular basis of disease. New opportunities now arise to predict disease by genetic testing, and in some cases to prevent disease through surveillance or other specific interventions. Increasingly it will be possible to test for predisposition to disease, to develop new treatments or to tailor available treatments more specifically to an individual’s genetic make-up.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Collins, F.S., Patrinos, A., 1998, New goals for the U.S. Human Genome Project: 1998–2003 Science 282(5389):682–689.
Evans, G.A., 1998, The Human Genome Project: applications in the diagnosis and treatment of neurologic disease. Arch Neurol 55(10):1287–1290.
Ferrari, M., Stenirri, S., Bonini, P., Cremonesi, L., 2003, Molecular diagnostics by microelectronic microchips. Clin Chem Lab Med 41(4):462–467.
Goldstein, J.L., Schrott, H.G., Hazzard, W.R., Bierman, E.L., Motulsky, A.G., 1973, Hyperlipidemia in coronary heart disease II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia. Clin Invest 52(7):1544–1568.
Khoury, M.J., 2003, Genetics and genomics in practice: the continuum from genetic disease to genetic information in health and disease. Gen Med 5(4):261–268.
Miki, Y., Swensen, J., Shattuck-Eidens, D., Futreal, P.A., Harshman, K., Tavtigian, S., Liu, Q., Cochran, C., Bennett, L.M., Ding, W., et al., 1994, A strong candidate for the breast and ovarian cancer susceptibility gene, BRCA1. Science 266(5182):66–71.
Miller, M.P., Kumar, S., 2001, Understanding human disease mutations through the use of interspecific genetic variation. Hum Mol Genet 10(21):2319–2328.
Nathans, D.G., Orkins, S.H., 2009, Musing on genome medicine: genome wide association studies. Genome Med 1(1):3
Peltonen, L., 2001, The molecular dissection of human diseases after the human genome project. Pharmacogenome J 1(1):5–6.
Phillips, K.A., Veenstra, D.L., Oren, E., Lee, J.K., Sadee, W., 2001, Potential role of pharmacogenomics in reducing adverse drug reactions: a systematic review. JAMA 286(18):2270–2279.
Risch, N., Burchard, E., Ziv, E., Tang, H., 2003, Categorization of humans in biomedical research: genes, race, and disease. Genome Biol 3(7):1–12.
Sachidanandam, R., Weissman, D., Schmidt, S.C., Kakol, J.M., Stein, L.D., Marth, G., Sherry, S., Mullikin, J.C., Mortimore, B.J., Willey, D.L., 2001, A map of the human genome sequence variation containing 1.42 million single nucleotide polymorphisms. Nature 409(6822):928–933.
Suh, Y., Vijg J., 2005, SNP discovery in associating genetic variation with human disease phenotypes. Mutat Res 573(1–2):41–53.
Van Ommen, G.-J.B., 2002, The Human Genome Project and the future of diagnostics, treatment and prevention. J Inher Metab Dis 25(3):183–188.
Venter, J.C., Adams, M.D., Myers, E.W., Li, P.W., Mural, R.J., Sutton, G.G., Smith, H.O., Yandell, M., Evans, C.A., Holt, R.A., et al., 2001, The sequence of the human genome. Science 291(5507):1304–1351.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer Science+Business Media B.V.
About this chapter
Cite this chapter
Debnath, M., Prasad, G.B., Bisen, P.S. (2010). Impact of HGP on Molecular Diagnostics. In: Molecular Diagnostics: Promises and Possibilities. Springer, Dordrecht. https://doi.org/10.1007/978-90-481-3261-4_6
Download citation
DOI: https://doi.org/10.1007/978-90-481-3261-4_6
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-90-481-3260-7
Online ISBN: 978-90-481-3261-4
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)